Key result
Higher microvascular resistance reserve is linked to ~33% lower MACE risk in women.
Why the study?
Given the unique hemodynamic characteristics of women, additional considerations were needed to evaluate the diagnostic and prognostic applicability of the microvascular resistance reserve specifically in women compared with men.
Does the microvascular resistance reserve (MRR) accurately predict major adverse cardiac events in both women and men with stable coronary artery disease?
Cohort (n=1,836)
Yes
Does the microvascular resistance reserve (MRR) accurately predict major adverse cardiac events in both women and men with stable coronary artery disease?
Answers are grounded in this paper and cite their sources.
MRR provides comparable diagnostic and prognostic value for predicting long-term major adverse cardiac events in both women and men with stable coronary artery disease.
BACKGROUND: The microvascular resistance reserve (MRR) is an innovative index to assess the vasodilatory capacity of the coronary circulation while accounting for the presence of concomitant epicardial disease. The MRR has shown to be a valuable diagnostic and prognostic tool in the general coronary artery disease (CAD) population. However, considering the fundamental aspects of its assessment and the unique hemodynamic characteristics of women, it is crucial to provide additional considerations for evaluating the MRR specifically in women. AIM: The aim of this study was to assess the diagnostic and prognostic applicability of the MRR in women and assess the potential differences across different sexes. METHODS: From the ILIAS Registry, we enrolled all patients with a stable indication for invasive coronary angiography, ensuring complete physiological and follow-up data. We analyzed the diagnostic value by comparing differences between sexes and evaluated the prognostic value of the MRR specifically in women, comparing it to that in men. RESULTS: A total of 1494 patients were included of which 26% were women. The correlation between MRR and CFR was good and similar between women (r = 0.80, p < 0.005) and men (r = 0.81, p < 0.005). The MRR was an independent and important predictor of MACE in both women (HR 0.67, 0.47-0.96, p = 0.027) and men (HR 0.84, 0.74-0.95, p = 0.007). The optimal cut-off value for MRR in women was 2.8 and 3.2 in men. An abnormal MRR similarly predicted MACE at 5-year follow-up in both women and men. CONCLUSION: The MRR seems to be equally applicable in both women and men with stable coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Boerhout et al. (2024) conducted a cohort in Chronic coronary syndromes (n=1,836). Microvascular resistance reserve (MRR) vs. Per unit increase was evaluated on Major adverse cardiac events (MACE) at 5-year follow-up (HR 0.67, 95% CI 0.47-0.96, p=0.027). The microvascular resistance reserve was an independent predictor of major adverse cardiac events in women (HR 0.67) and men (HR 0.84), showing equal diagnostic and prognostic applicability across sexes.
Synapse has enriched 10 related papers. Consider them for comparative context: